Paid Clinical Trials in White Plains, NY
As of August 2026, 43 paid clinical trials are recruiting in White Plains, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
White Plains offers studies at sites including White Plains Hospital for conditions such as Aggression, Atrial Fibrillation, Autism Spectrum Disorder, Cognitive Impairment. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in White Plains
Trials by drug in White Plains
Filter results
41 clinical trials
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
GEMINI-NSCLC: NSCLC Biomarker Study
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Vivistim Registry for Paired VNS Therapy (GRASP)
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Pancreatic Cancer Early Detection Consortium
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Using tDCS in Speech-based Stroke Rehabilitation
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
Mind-Body Skills Group for Graduate Students
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
Q Therapeutic System for Chronic Stroke Recovery
Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Observational Study Protocol: LIVER-R
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Top Research Study Locations in White Plains
Researchers run research studies in White Plains, NY at 17 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| White Plains Hospital | Acute Myeloid Leukemia, Atrial Fibrillation, Breast Neoplasms | 12 |
| Dickstein Cancer Treatment Center | Stage IIIB Lung Cancer AJCC v8, Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Anatomic Stage II Breast Cancer AJCC v8 | 5 |
| Burke Rehabilitation Hospital | Apraxia of Speech, Brain Injury, Cerebrovascular Accident (CVA) | 4 |
| Burke Neurological Institute | Cerebral Palsy, Children, Spastic Cerebral Palsy | 2 |
| Center for Autism and the Developing Brain | Autism Spectrum Disorder, Aggression, Challenging Behaviour | 2 |
| White Plains Hospital Physician Associates | Limited Stage Small Cell Lung Cancer, Triple Negative Breast Cancer | 2 |
| Burke Rehabilitation Center | Atrial Fibrillation, Intracerebral Hemorrhage | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Local Institution - 0020 | Schizophrenia | 1 |
| Local Institution - 0618 | Carcinoma, Non-Small-Cell Lung | 1 |
| National Health Promotion Associates | E Cig Use, Prescription Drug Misuse, Vaping | 1 |
| NewYork-Presbyterian/Weill Cornell Medical Center Westchester Division | Aggression, Schizoaffecitve Disorder, Schizophrenia Disorder | 1 |
| Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine | Depression, Suicidal Ideation, Suicide, Attempted | 1 |
| Weill Cornell Medical College | Anxiety Generalized, Depressive Symptoms, Mood Change | 1 |
| Weill Cornell Medicine | Cognitive Impairment, Depression, Pain | 1 |
| White Plains Hospital Center for Cancer Care - Oncology | Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer | 1 |
| White Plains Hospital-Center for Cancer Care | Hematologic Malignancies, Solid Tumors | 1 |
Active & Upcoming Studies in White Plains (2026)
Recruiting trials in White Plains grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (22 active studies)
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. · Phase 2, Phase 3 · Eikon Therapeutics
- A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014) · Phase 3 · Merck Sharp & Dohme LLC
Mental health & behavior (6 active studies)
- A Virtual Reality Mindfulness Application for Aggression in Schizophrenia · Manhattan Psychiatric Center
- Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · Bristol-Myers Squibb
Neurology & pain (3 active studies)
- Q Therapeutic System for Chronic Stroke Recovery · Burke Rehabilitation Hospital
- EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment · BrainQ Technologies Ltd.
Cardiovascular (2 active studies)
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation · Phase 3 · Johns Hopkins University
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery · Phase 3 · Yale University
Pediatric (1 active study)
- Effects of Transcranial Random Noise Stimulation on Motor Learning in Typically Developing Adolescents · EARLY_Phase 1 · Burke Medical Research Institute
Common conditions studied in White Plains
- Aggression (2 active studies)
- Atrial Fibrillation (2 active studies)
- Autism Spectrum Disorder (2 active studies)
- Cognitive Impairment (2 active studies)
- Depression (2 active studies)
- Non-small Cell Lung Cancer (2 active studies)
Leading research sponsors in White Plains
- AstraZeneca
- Merck Sharp & Dohme LLC
- National Cancer Institute (NCI)
- Weill Medical College of Cornell University
- BioNTech SE
Frequently asked questions
How many paid clinical trials are currently recruiting in White Plains?
There are approximately 43 recruiting clinical trials in White Plains, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in White Plains pay participants?
Most recruiting trials in White Plains compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in White Plains?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in White Plains?
The most common conditions under active study in White Plains include Aggression (2), Atrial Fibrillation (2), Autism Spectrum Disorder (2), Cognitive Impairment (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in White Plains?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in White Plains on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in White Plains?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in White Plains?
Recruiting research sites in White Plains include White Plains Hospital, Dickstein Cancer Treatment Center, Burke Rehabilitation Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in White Plains right now?
The largest active categories in White Plains are Cancer & tumors (22), Mental health & behavior (6), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.